Loading stock data…
$1.59-0.08 (-4.79%)
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally.
Intelligent Bio Solutions Inc. in the Healthcare sector is trading at $1.59 with a market capitalization of $7M. Wall Street consensus targets $12.00 (1 analysts), implying a +654.7% move over the next 12 months. The stock is currently near its 52-week low of $1.35, remaining 55.0% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.15M↑ | $1.06M↑ | $896,774↓ | $1.11M↑ | $843,884 |
| Gross Profit | $536,583↑ | $535,381↑ | $459,739↓ | $518,291↑ | $335,577 |
| Operating Income | -$3.96M↓ | -$2.94M↓ | -$2.61M↑ | -$2.74M↑ | -$2.88M |
| Net Income | -$3.91M↓ | -$2.86M↓ | -$2.68M↑ | -$2.98M↑ | -$3.09M |
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelli...